4DMedical Unveils Bold Expansion Plans in M&A Call

4DMedical Limited (FDMDF) hosted an M&A call on June 8, 2026, to discuss its latest business moves. The session covered recent deals, commercial progress, and expansion into new markets. Key executives and an industry analyst took part in the discussion. The call took place at 9:00 PM EDT and was led by John Hester from Bell Potter Securities Limited. He guided the conversation on 4DMedical’s commercialisation efforts, including updates on the CLEAR study. This research targets the pulmonary embolism diagnosis market, currently dominated by CT pulmonary angiograms.

Representing 4DMedical were Andreas Fouras, the company’s founder and CEO, along with Chief Commercial Officer Matt Tucker, CFO Julian Sutton, and Chief Commercialization Officer Matthew Tucker. They highlighted recent achievements, such as signing SimonMed, a 17-site outpatient imaging provider operating across 10 U.S. states. The team also announced the acquisition of contextflow, marking the company’s first step into Europe’s medical imaging sector. The discussion focused on how these developments would shape 4DMedical’s future growth and market presence.

The call outlined 4DMedical’s strategic expansion through partnerships and acquisitions. The CLEAR study and new deals position the company for broader influence in pulmonary diagnostics and imaging. These moves signal a push into both U.S. and European healthcare markets.